LTR Pharma Limited
LTPLF
$0.27
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.08M | 23.62M | 2.07M | 2.02M | 4.10M |
| Total Receivables | 365.70K | 409.70K | 176.90K | 172.90K | 118.80K |
| Inventory | 1.30K | 1.50K | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | 80.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 21.45M | 24.03M | 2.25M | 2.20M | 4.30M |
|
|
|||||
| Total Current Assets | 21.45M | 24.03M | 2.25M | 2.20M | 4.30M |
| Net Property, Plant & Equipment | 5.80K | 6.50K | 1.10K | 1.10K | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 36.70K | 41.10K | -- | -- | 203.40K |
| Total Assets | 21.49M | 24.08M | 2.25M | 2.20M | 4.51M |
|
|
|||||
| Total Accounts Payable | 157.90K | 176.90K | 161.70K | 158.10K | 144.30K |
| Total Accrued Expenses | 72.00K | 80.60K | 87.10K | 85.10K | 79.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 38.30K | 42.90K | 37.10K | 36.30K | -- |
| Total Other Current Liabilities | 38.30K | 42.90K | 37.10K | 36.30K | -- |
| Total Current Liabilities | 268.20K | 300.40K | 285.90K | 279.50K | 223.70K |
|
|
|||||
| Total Current Liabilities | 268.20K | 300.40K | 285.90K | 279.50K | 223.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 268.20K | 300.40K | 285.90K | 279.50K | 223.70K |
|
|
|||||
| Common Stock & APIC | 27.30M | 30.59M | 7.17M | 7.01M | 7.32M |
| Retained Earnings | -7.35M | -8.24M | -6.32M | -6.18M | -3.45M |
| Treasury Stock & Other | 1.28M | 1.43M | 1.12M | 1.09M | 408.60K |
| Total Common Equity | 21.23M | 23.78M | 1.96M | 1.92M | 4.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.23M | 23.78M | 1.96M | 1.92M | 4.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 21.23M | 23.78M | 1.96M | 1.92M | 4.28M |
|
|
|||||